Ankylosing Spondylitis Trial, Recruiting NCT04274374 Sponsor: University Hospital, Clermont-Ferrand Condition: Ankylosing Spondylitis
Back to Ankylosing Spondylitis

Ankylosing Spondylitis Trial, Recruiting

NCT04274374
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with axial spondyloarthritis (a type of inflammatory joint disease affecting the spine) according to recognised medical guidelines
  • Your rheumatologist (joint specialist) does not plan to change your treatment during the 4 months after joining the trial
  • You have been on a stable treatment plan using anti-inflammatory or disease-modifying medicines for at least 3 months, and have not had a steroid injection in the month before joining
  • You are able to follow a gluten-free diet, give written consent to participate, and meet the study's requirements

Who may not be able to join:

  • You are currently following any special diet, or have been on one in the 3 months before joining
  • You have a history of coeliac disease (a condition where gluten damages the gut)
  • You have taken antibiotics in the last 3 months, or are currently taking probiotic supplements
  • You are pregnant or breastfeeding
  • You are not covered by French social security (confirm with trial site)
  • You are under 18 years old, or are an adult who is legally protected or under court protection

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Marion Couderc, MD, University Hospital, Clermont-Ferrand

Phone: 334.73.754.963

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
7 October 2021
Est. completion
1 October 2025

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Assessment of the variation in quality of life evaluated variation inby the Assessment of SpondyloArthritis international Society (ASAS) Health Index

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov